Effect of long term intramuscular gold therapy on the seroprevalence of Helicobacter pylori in patients with early rheumatoid arthritis.
Paimela
L
L
Leirisalo-Repo
M
M
Kosunen
T U
TU
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000097:blood*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000382:microbiology*; D005260:Female; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D050607:Organogold Compounds; D012460:Sulfasalazine / Q000008:administration & dosage; D013997:Time Factors
D000907:Antibodies, Bacterial; D018501:Antirheumatic Agents; D050607:Organogold Compounds; D012460:Sulfasalazine